Healius Limited
ASX: HLS
Stabilising outlook overshadowed by persistent downtrend and weak momentum signals.
(Source: TradingView) 3-Month Performance Profile of HLS on a DTF compared to S&P/ASX 200 (XJO).
Healius Limited delivered a stabilising performance in 1H26, with revenue increasing 3.8% year-on-year to $688.1 million, supported by improved volume mix and ongoing cost redu
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
